Clínica Médica

Estudo randomizado | Dieta de baixo FODMAP reduz os sintomas em pacientes celíacos tratados e que persistem com sintomas.

25 Jan, 2022 | 14:34h

A low FODMAP diet reduces symptoms in treated celiac patients with ongoing symptoms – a randomized controlled trial – Clinical Gastroenterology and Hepatology

Comentário no Twitter

A low FODMAP diet reduces symptoms in ‘𝘁𝗿𝗲𝗮𝘁𝗲𝗱’ #celiac patients with ongoing symptoms – a randomized controlled trial.

Brilliant RCT! Important word in the title is… ‘Treated’ (ie in histopathological remission).😉

🔓 https://t.co/R7oSnNhsWI pic.twitter.com/d0wbAa2nFg

— Nick Trott (@trott_nick) January 22, 2022

Estudo de caso-controle | 3 doses de vacinas de mRNA foram associadas com redução nas infecções pelas variantes Ômicron e Delta do SARS-CoV-2 em comparação com 2 doses ou nenhuma vacinação.

25 Jan, 2022 | 12:07h

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants – JAMA

Editorial: Booster Vaccination to Prevent COVID-19 in the Era of Omicron: An Effective Part of a Layered Public Health Approach – JAMA

Comentários: New data show booster doses protect against Omicron – CIDRAP

Boosters provide the best protection against Omicron variant, CDC studies show, raising new questions about what it means to be fully vaccinated – CNN

Estudos do CDC relacionados:

COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 – CDC Morbidity and Mortality Weekly Report

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022 – CDC Morbidity and Mortality Weekly Report

Comentário no Twitter

Study suggests receipt of 3 doses of mRNA #COVID19 vaccine, vs 2 doses or being unvaccinated, was associated with protection against both the Omicron and Delta variants; higher odds ratios for Omicron suggest less protection for Omicron than for Delta. https://t.co/kOZh0fq5TL

— JAMA (@JAMA_current) January 21, 2022

CDC da Europa sobre a Ômicron: “Entre os casos de Ômicron reportados ao TESSy, 1,14% foram internados, 0,16% necessitaram de internação em UTI/suporte respiratório e 0,06% morreram.”

25 Jan, 2022 | 12:05h

Weekly epidemiological update: Omicron variant of concern (VOC) – week 2 (data as of 20 January 2022) EU/EEA – European Centre for Disease Prevention and Control (ECDC)

Diretriz atualizada | Medicamentos e agentes biológicos recomendados para pacientes adultos com COVID-19.

25 Jan, 2022 | 12:04h

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 – Covid-19 Advisory for Ontario

Comentário no Twitter (fio – clique para saber mais)

🔥JUST RELEASED: New clinical guidelines for COVID now including #Paxlovid (nirmatrelvir/ritonavir).

A 🧵 on why Paxlovid is NOT first-line.https://t.co/h0puYpiFOK

— Andrew Morris (@ASPphysician) January 22, 2022